Mark R. Sullivan
2019
In 2019, Mark R. Sullivan earned a total compensation of $937.7K as General Counsel and Corporate Secretary at Eleven Biotherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $140,875 |
|---|---|
| Option Awards | $335,894 |
| Salary | $456,949 |
| Other | $4,000 |
| Total | $937,718 |
Sullivan received $456.9K in salary, accounting for 49% of the total pay in 2019.
Sullivan also received $140.9K in non-equity incentive plan, $335.9K in option awards and $4K in other compensation.
Rankings
In 2019, Mark R. Sullivan's compensation ranked 9,566th out of 13,971 executives tracked by ExecPay. In other words, Sullivan earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,566 out of 13,971 | 32nd |
Division Manufacturing | 3,848 out of 5,701 | 33rd |
Major group Chemicals And Allied Products | 1,462 out of 2,200 | 34th |
Industry group Drugs | 1,249 out of 1,886 | 34th |
Industry Pharmaceutical Preparations | 928 out of 1,398 | 34th |
Source: SEC filing on March 30, 2020.
Sullivan's colleagues
We found three more compensation records of executives who worked with Mark R. Sullivan at Eleven Biotherapeutics in 2019.